Literature DB >> 24722446

Alterations in the ubiquitin proteasome system in persistent but not reversible proteinuric diseases.

Maire Beeken1, Maja T Lindenmeyer2, Simone M Blattner3, Victoria Radón1, Jun Oh4, Tobias N Meyer5, Diana Hildebrand6, Hartmut Schlüter6, Anna T Reinicke1, Jan-Hendrik Knop1, Anuradha Vivekanandan-Giri3, Silvia Münster1, Marlies Sachs1, Thorsten Wiech7, Subramaniam Pennathur3, Clemens D Cohen2, Matthias Kretzler3, Rolf A K Stahl1, Catherine Meyer-Schwesinger8.   

Abstract

Podocytes are the key cells affected in nephrotic glomerular kidney diseases, and they respond uniformly to injury with cytoskeletal rearrangement. In nephrotic diseases, such as membranous nephropathy and FSGS, persistent injury often leads to irreversible structural damage, whereas in minimal change disease, structural alterations are mostly transient. The factors leading to persistent podocyte injury are currently unknown. Proteolysis is an irreversible process and could trigger persistent podocyte injury through degradation of podocyte-specific proteins. We, therefore, analyzed the expression and functional consequence of the two most prominent proteolytic systems, the ubiquitin proteasome system (UPS) and the autophagosomal/lysosomal system, in persistent and transient podocyte injuries. We show that differential upregulation of both proteolytic systems occurs in persistent human and rodent podocyte injury. The expression of specific UPS proteins in podocytes differentiated children with minimal change disease from children with FSGS and correlated with poor clinical outcome. Degradation of the podocyte-specific protein α-actinin-4 by the UPS depended on oxidative modification in membranous nephropathy. Notably, the UPS was overwhelmed in podocytes during experimental glomerular disease, resulting in abnormal protein accumulation and compensatory upregulation of the autophagosomal/lysosomal system. Accordingly, inhibition of both proteolytic systems enhanced proteinuria in persistent nephrotic disease. This study identifies altered proteolysis as a feature of persistent podocyte injury. In the future, specific UPS proteins may serve as new biomarkers or therapeutic targets in persistent nephrotic syndrome.
Copyright © 2014 by the American Society of Nephrology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24722446      PMCID: PMC4214514          DOI: 10.1681/ASN.2013050522

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  64 in total

1.  Enac degradation in A6 cells by the ubiquitin-proteosome proteolytic pathway.

Authors:  B Malik; L Schlanger; O Al-Khalili; H F Bao; G Yue; S R Price; W E Mitch; D C Eaton
Journal:  J Biol Chem       Date:  2001-01-26       Impact factor: 5.157

Review 2.  The ubiquitin-mediated proteolytic pathway: mode of action and clinical implications.

Authors:  A Ciechanover; A Orian; A L Schwartz
Journal:  J Cell Biochem Suppl       Date:  2000

3.  A single WW domain is the predominant mediator of the interaction between the human ubiquitin-protein ligase Nedd4 and the human epithelial sodium channel.

Authors:  J Shaun Lott; Sarah J Coddington-Lawson; Paul H Teesdale-Spittle; Fiona J McDonald
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

4.  Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress.

Authors:  Ulrike Seifert; Lukasz P Bialy; Frédéric Ebstein; Dawadschargal Bech-Otschir; Antje Voigt; Friederike Schröter; Timour Prozorovski; Nicole Lange; Janos Steffen; Melanie Rieger; Ulrike Kuckelkorn; Orhan Aktas; Peter-M Kloetzel; Elke Krüger
Journal:  Cell       Date:  2010-08-20       Impact factor: 41.582

5.  Enhancement of proteasome function by PA28α overexpression protects against oxidative stress.

Authors:  Jie Li; Saul R Powell; Xuejun Wang
Journal:  FASEB J       Date:  2010-11-23       Impact factor: 5.191

Review 6.  Oxidative stress-mediated regulation of proteasome complexes.

Authors:  Charity T Aiken; Robyn M Kaake; Xiaorong Wang; Lan Huang
Journal:  Mol Cell Proteomics       Date:  2011-05       Impact factor: 5.911

7.  Experimental glomerulonephritis.

Authors:  D J Salant; A V Cybulsky
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

Review 8.  Degradation of oxidized proteins in mammalian cells.

Authors:  T Grune; T Reinheckel; K J Davies
Journal:  FASEB J       Date:  1997-06       Impact factor: 5.191

9.  Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice.

Authors:  Björn Hartleben; Markus Gödel; Catherine Meyer-Schwesinger; Shuya Liu; Theresa Ulrich; Sven Köbler; Thorsten Wiech; Florian Grahammer; Sebastian J Arnold; Maja T Lindenmeyer; Clemens D Cohen; Hermann Pavenstädt; Dontscho Kerjaschki; Noboru Mizushima; Andrey S Shaw; Gerd Walz; Tobias B Huber
Journal:  J Clin Invest       Date:  2010-04       Impact factor: 14.808

10.  Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

Authors:  Marco Prunotto; Maria Luisa Carnevali; Giovanni Candiano; Corrado Murtas; Maurizio Bruschi; Emilia Corradini; Antonella Trivelli; Alberto Magnasco; Andrea Petretto; Laura Santucci; Silvia Mattei; Rita Gatti; Francesco Scolari; Peter Kador; Landino Allegri; Gian Marco Ghiggeri
Journal:  J Am Soc Nephrol       Date:  2010-02-11       Impact factor: 10.121

View more
  10 in total

1.  Role of A20/TNFAIP3 deficiency in lupus nephritis in MRL/lpr mice.

Authors:  Ling Sun; Lu-Xi Zou; Yu-Chen Han; Dong-Dong Zhu; Ting Chen; Jie Wang
Journal:  Clin Exp Nephrol       Date:  2019-12-07       Impact factor: 2.801

Review 2.  Podocyte-actin dynamics in health and disease.

Authors:  Luca Perico; Sara Conti; Ariela Benigni; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

3.  Impairment of Proteasome Function in Podocytes Leads to CKD.

Authors:  Shin-Ichi Makino; Naritoshi Shirata; Juan Alejandro Oliva Trejo; Kanae Yamamoto-Nonaka; Hiroyuki Yamada; Takafumi Miyake; Kiyoshi Mori; Takahiko Nakagawa; Yoshitaka Tashiro; Hirofumi Yamashita; Motoko Yanagita; Ryosuke Takahashi; Katsuhiko Asanuma
Journal:  J Am Soc Nephrol       Date:  2021-01-28       Impact factor: 10.121

4.  Dysregulated Dynein-Mediated Trafficking of Nephrin Causes INF2-related Podocytopathy.

Authors:  Hua Sun; Chandra Perez-Gill; Johannes S Schlöndorff; Balajikarthick Subramanian; Martin R Pollak
Journal:  J Am Soc Nephrol       Date:  2020-12-22       Impact factor: 10.121

Review 5.  Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.

Authors:  Agnieszka Pozdzik; Isabelle Brochériou; Cristina David; Fahd Touzani; Jean Michel Goujon; Karl Martin Wissing
Journal:  Biomed Res Int       Date:  2018-01-08       Impact factor: 3.411

6.  Role of the ubiquitin/proteasome system on ACTH turnover in rat corticotropes.

Authors:  Antonella Sesta; Maria Francesca Cassarino; Francesco Cavagnini; Francesca Pecori Giraldi
Journal:  Endocrine       Date:  2018-03-13       Impact factor: 3.633

Review 7.  Urinary Protein and Peptide Markers in Chronic Kidney Disease.

Authors:  Natalia Chebotareva; Anatoliy Vinogradov; Valerie McDonnell; Natalia V Zakharova; Maria I Indeykina; Sergey Moiseev; Evgeny N Nikolaev; Alexey S Kononikhin
Journal:  Int J Mol Sci       Date:  2021-11-09       Impact factor: 5.923

Review 8.  Lysosome function in glomerular health and disease.

Authors:  Catherine Meyer-Schwesinger
Journal:  Cell Tissue Res       Date:  2021-01-12       Impact factor: 4.051

9.  Association of UBE3C Variants with Reduced Kidney Function in Patients with Diabetic Kidney Disease.

Authors:  Ying-Chun Chen; Mei-Yi Wu; Zhi-Lei Yu; Wan-Hsuan Chou; Yi-Ting Lai; Chih-Chin Kao; Imaniar Noor Faridah; Mai-Szu Wu; Wei-Chiao Chang
Journal:  J Pers Med       Date:  2020-11-06

10.  Cytoskeletal protein degradation in brain death donor kidneys associates with adverse posttransplant outcomes.

Authors:  Rebecca H Vaughan; Jean-Claude Kresse; Louise K Farmer; Marie L Thézénas; Benedikt M Kessler; Jan H N Lindeman; Edward J Sharples; Gavin I Welsh; Rikke Nørregaard; Rutger J Ploeg; Maria Kaisar
Journal:  Am J Transplant       Date:  2022-02-04       Impact factor: 9.369

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.